Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$296.12M-$296.12MderivedN/M vs Q4 2023 EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$579,767,000+1.7% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Incomederived-$275,427,000N/M Operating Cash Flowderived$71,001,000−36.5% Free Cash Flowderived$48,746,000−39.0% ended Dec 31, 2024 · filed Feb 28, 2025 · 59 d after period end